Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$20.31
-0.01-0.05%
Last update: Dec 8, 9:30 AM
Comments
Loading...
Syndax Pharmaceuticals (SNDX) Stock Price, Quote, News & History
SNDXNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Syndax Pharmaceuticals (SNDX) stock?
You can purchase shares of Syndax Pharmaceuticals (NASDAQ:SNDX) through any online brokerage.
Who are Syndax Pharmaceuticals (SNDX) competitors?
Other companies in Syndax Pharmaceuticals’s space includes: Immunome Inc (NASDAQ:IMNM), Twist Bioscience Corp (NASDAQ:TWST), Upstream Bio Inc (NASDAQ:UPB), NuCana PLC (NASDAQ:NCNA) and Agios Pharmaceuticals Inc (NASDAQ:AGIO).
What is the forecast, or price target, for Syndax Pharmaceuticals (SNDX) stock?
Syndax Pharmaceuticals has a consensus price target of $36.05.
What is the current price for Syndax Pharmaceuticals (SNDX)?
The stock price for Syndax Pharmaceuticals (NASDAQ: SNDX) is $20.31 last updated December 8, 2025 at 9:30 AM EST.
Does Syndax Pharmaceuticals (SNDX) pay a dividend?
There are no upcoming dividends for Syndax Pharmaceuticals.
When is Syndax Pharmaceuticals (NASDAQ:SNDX) reporting earnings?
Syndax Pharmaceuticals does not have any upcoming earnings scheduled.
Is Syndax Pharmaceuticals (SNDX) going to split?
There is no upcoming split for Syndax Pharmaceuticals.
What sector and industry does Syndax Pharmaceuticals (SNDX) operate in?
Syndax Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
